Is BBNX or APYX more profitable?

Apyx Medical has a net margin of -16.40% compared to Beta Bionics' net margin of -60.27%. Beta Bionics' return on equity of -23.00% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Beta Bionics -60.27% -23.00% -20.55% Apyx Medical -16.40% -88.47% -14.94%

Does the media favor BBNX or APYX?

In the previous week, Beta Bionics had 8 more articles in the media than Apyx Medical. MarketBeat recorded 10 mentions for Beta Bionics and 2 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.62 beat Beta Bionics' score of 0.29 indicating that Apyx Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Apyx Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TCMD or APYX?

In the previous week, Tactile Systems Technology and Tactile Systems Technology both had 2 articles in the media. Tactile Systems Technology's average media sentiment score of 0.96 beat Apyx Medical's score of 0.62 indicating that Tactile Systems Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is APYX or BWAY more profitable?

Brainsway has a net margin of 15.68% compared to Apyx Medical's net margin of -16.40%. Brainsway's return on equity of 12.28% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -16.40% -88.47% -14.94% Brainsway 15.68% 12.28% 7.75%

Does the media refer more to APYX or BWAY?

In the previous week, Brainsway had 2 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for Brainsway and 2 mentions for Apyx Medical. Brainsway's average media sentiment score of 1.10 beat Apyx Medical's score of 0.62 indicating that Brainsway is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Brainsway 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, MDXG or APYX?

MiMedx Group has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiMedx Group $418.63M 1.37 $48.58M $0.20 19.25 Apyx Medical $52.84M 3.55 -$11.21M -$0.22 N/A

Is MDXG or APYX more profitable?

MiMedx Group has a net margin of 7.88% compared to Apyx Medical's net margin of -16.40%. MiMedx Group's return on equity of 21.03% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets MiMedx Group 7.88% 21.03% 15.92% Apyx Medical -16.40% -88.47% -14.94%

Does the media refer more to MDXG or APYX?

In the previous week, MiMedx Group and MiMedx Group both had 2 articles in the media. MiMedx Group's average media sentiment score of 0.93 beat Apyx Medical's score of 0.62 indicating that MiMedx Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiMedx Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Apyx Medical (APYX) Competitors

$4.47 -0.22 (-4.69%)

Closing price 03:59 PM Eastern

Extended Trading

$4.49 +0.02 (+0.34%)

As of 06:30 PM Eastern

Compare

APYX vs. SGP, BBNX, TCMD, BWAY, and MDXG

Should you buy Apyx Medical stock or one of its competitors? MarketBeat compares Apyx Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Apyx Medical include Spyglass Pharma (SGP), Beta Bionics (BBNX), Tactile Systems Technology (TCMD), Brainsway (BWAY), and MiMedx Group (MDXG). These companies are all part of the "medical equipment" industry.

How does Apyx Medical compare to Spyglass Pharma?

Apyx Medical (NASDAQ:APYX) and Spyglass Pharma (NASDAQ:SGP) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

55.3% of Apyx Medical shares are held by institutional investors. 15.2% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Spyglass Pharma has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Spyglass Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	3.55	-$11.21M	-$0.22	N/A
Spyglass Pharma	N/A	N/A	N/A	-$6.41	N/A

Apyx Medical presently has a consensus price target of $6.50, indicating a potential upside of 45.41%. Spyglass Pharma has a consensus price target of $45.00, indicating a potential upside of 102.16%. Given Spyglass Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Spyglass Pharma is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Spyglass Pharma	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Apyx Medical had 1 more articles in the media than Spyglass Pharma. MarketBeat recorded 2 mentions for Apyx Medical and 1 mentions for Spyglass Pharma. Spyglass Pharma's average media sentiment score of 1.89 beat Apyx Medical's score of 0.62 indicating that Spyglass Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Apyx Medical	Positive
Spyglass Pharma	Very Positive

Spyglass Pharma has a net margin of 0.00% compared to Apyx Medical's net margin of -16.40%. Spyglass Pharma's return on equity of 0.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
Spyglass Pharma	N/A	N/A	N/A

Summary

Spyglass Pharma beats Apyx Medical on 8 of the 14 factors compared between the two stocks.

How does Apyx Medical compare to Beta Bionics?

Beta Bionics (NASDAQ:BBNX) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

Apyx Medical has a net margin of -16.40% compared to Beta Bionics' net margin of -60.27%. Beta Bionics' return on equity of -23.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beta Bionics	-60.27%	-23.00%	-20.55%
Apyx Medical	-16.40%	-88.47%	-14.94%

Beta Bionics has a beta of 3.4, indicating that its share price is 240% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market.

In the previous week, Beta Bionics had 8 more articles in the media than Apyx Medical. MarketBeat recorded 10 mentions for Beta Bionics and 2 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.62 beat Beta Bionics' score of 0.29 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beta Bionics	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Apyx Medical has lower revenue, but higher earnings than Beta Bionics. Apyx Medical is trading at a lower price-to-earnings ratio than Beta Bionics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beta Bionics	$100.25M	6.97	-$73.20M	-$1.51	N/A
Apyx Medical	$52.84M	3.55	-$11.21M	-$0.22	N/A

Beta Bionics currently has a consensus price target of $19.70, indicating a potential upside of 25.72%. Apyx Medical has a consensus price target of $6.50, indicating a potential upside of 45.41%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts clearly believe Apyx Medical is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

55.3% of Apyx Medical shares are owned by institutional investors. 5.3% of Beta Bionics shares are owned by company insiders. Comparatively, 15.2% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Apyx Medical beats Beta Bionics on 9 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to Tactile Systems Technology?

Tactile Systems Technology (NASDAQ:TCMD) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by insiders. Comparatively, 15.2% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tactile Systems Technology has a net margin of 5.91% compared to Apyx Medical's net margin of -16.40%. Tactile Systems Technology's return on equity of 9.70% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
Apyx Medical	-16.40%	-88.47%	-14.94%

Tactile Systems Technology has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	2.04	$19.09M	$0.88	33.84
Apyx Medical	$52.84M	3.55	-$11.21M	-$0.22	N/A

Tactile Systems Technology presently has a consensus target price of $38.60, suggesting a potential upside of 29.62%. Apyx Medical has a consensus target price of $6.50, suggesting a potential upside of 45.41%. Given Apyx Medical's higher possible upside, analysts plainly believe Apyx Medical is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Tactile Systems Technology has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market.

In the previous week, Tactile Systems Technology and Tactile Systems Technology both had 2 articles in the media. Tactile Systems Technology's average media sentiment score of 0.96 beat Apyx Medical's score of 0.62 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Tactile Systems Technology beats Apyx Medical on 11 of the 15 factors compared between the two stocks.

How does Apyx Medical compare to Brainsway?

Apyx Medical (NASDAQ:APYX) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

In the previous week, Brainsway had 2 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for Brainsway and 2 mentions for Apyx Medical. Brainsway's average media sentiment score of 1.10 beat Apyx Medical's score of 0.62 indicating that Brainsway is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Brainsway	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 15.2% of Apyx Medical shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Brainsway has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	3.55	-$11.21M	-$0.22	N/A
Brainsway	$52.22M	11.92	$7.57M	$0.35	44.31

Brainsway has a net margin of 15.68% compared to Apyx Medical's net margin of -16.40%. Brainsway's return on equity of 12.28% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
Brainsway	15.68%	12.28%	7.75%

Apyx Medical has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market. Comparatively, Brainsway has a beta of 1.2, meaning that its share price is 20% more volatile than the broader market.

Apyx Medical presently has a consensus target price of $6.50, indicating a potential upside of 45.41%. Brainsway has a consensus target price of $16.00, indicating a potential upside of 3.16%. Given Apyx Medical's higher probable upside, analysts clearly believe Apyx Medical is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Brainsway	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

Brainsway beats Apyx Medical on 11 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to MiMedx Group?

MiMedx Group (NASDAQ:MDXG) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

MiMedx Group currently has a consensus target price of $8.50, suggesting a potential upside of 120.78%. Apyx Medical has a consensus target price of $6.50, suggesting a potential upside of 45.41%. Given MiMedx Group's stronger consensus rating and higher possible upside, research analysts clearly believe MiMedx Group is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

MiMedx Group has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$418.63M	1.37	$48.58M	$0.20	19.25
Apyx Medical	$52.84M	3.55	-$11.21M	-$0.22	N/A

MiMedx Group has a net margin of 7.88% compared to Apyx Medical's net margin of -16.40%. MiMedx Group's return on equity of 21.03% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	7.88%	21.03%	15.92%
Apyx Medical	-16.40%	-88.47%	-14.94%

79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 2.5% of MiMedx Group shares are owned by insiders. Comparatively, 15.2% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, MiMedx Group and MiMedx Group both had 2 articles in the media. MiMedx Group's average media sentiment score of 0.93 beat Apyx Medical's score of 0.62 indicating that MiMedx Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiMedx Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiMedx Group has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market.

Summary

MiMedx Group beats Apyx Medical on 13 of the 16 factors compared between the two stocks.

Get Apyx Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APYX vs. The Competition

Export

Metric	Apyx Medical	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$196.57M	$8.64B	$6.87B	$12.45B
Dividend Yield	N/A	2.52%	2.67%	6.16%
P/E Ratio	-20.32	15.85	27.51	24.87
Price / Sales	3.55	7.22	540.69	102.84
Price / Cash	N/A	17.76	48.53	58.59
Price / Book	11.46	3.42	11.01	6.54
Net Income	-$11.21M	$226.25M	$3.57B	$336.70M
7 Day Performance	9.56%	2.27%	2.56%	3.31%
1 Month Performance	12.03%	-4.20%	0.89%	1.68%
1 Year Performance	98.67%	0.15%	36.84%	31.96%

Apyx Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APYX Apyx Medical	3.0605 of 5 stars	$4.47 -4.7%	$6.50 +45.4%	+117.1%	$196.57M	$52.84M	N/A	270	News Coverage
SGP Spyglass Pharma	2.7354 of 5 stars	$19.67 +1.7%	$45.00 +128.8%	N/A	$657.63M	N/A	N/A	65
BBNX Beta Bionics	3.4284 of 5 stars	$13.67 -0.2%	$19.70 +44.1%	+12.8%	$610.50M	$110.24M	N/A	294
TCMD Tactile Systems Technology	3.7762 of 5 stars	$26.45 +0.9%	$38.60 +45.9%	+192.7%	$591.42M	$329.52M	30.06	1,086	News Coverage
BWAY Brainsway	3.2688 of 5 stars	$14.39 +0.1%	$16.00 +11.2%	+129.5%	$576.54M	$52.22M	41.12	120	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APYX) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apyx Medical (APYX) Competitors

APYX vs. SGP, BBNX, TCMD, BWAY, and MDXG

How does Apyx Medical compare to Spyglass Pharma?

Summary

How does Apyx Medical compare to Beta Bionics?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Summary

How does Apyx Medical compare to Brainsway?

Summary

How does Apyx Medical compare to MiMedx Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apyx Medical (APYX) Competitors

APYX vs. SGP, BBNX, TCMD, BWAY, and MDXG

How does Apyx Medical compare to Spyglass Pharma?

Do institutionals & insiders believe in APYX or SGP?

Which has stronger earnings and valuation, APYX or SGP?

Do analysts recommend APYX or SGP?

Does the media prefer APYX or SGP?

Is APYX or SGP more profitable?

Summary

How does Apyx Medical compare to Beta Bionics?

Is BBNX or APYX more profitable?

Which has more risk and volatility, BBNX or APYX?

Does the media favor BBNX or APYX?

Which has preferable valuation and earnings, BBNX or APYX?

Do analysts rate BBNX or APYX?

Do insiders and institutionals have more ownership in BBNX or APYX?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Do institutionals & insiders have more ownership in TCMD or APYX?

Is TCMD or APYX more profitable?

Which has stronger earnings & valuation, TCMD or APYX?

Do analysts rate TCMD or APYX?

Which has more volatility and risk, TCMD or APYX?

Does the media favor TCMD or APYX?

Summary

How does Apyx Medical compare to Brainsway?

Does the media refer more to APYX or BWAY?

Do institutionals and insiders believe in APYX or BWAY?

Which has higher earnings and valuation, APYX or BWAY?

Is APYX or BWAY more profitable?

Which has more volatility and risk, APYX or BWAY?

Do analysts prefer APYX or BWAY?

Summary

How does Apyx Medical compare to MiMedx Group?

Do analysts recommend MDXG or APYX?

Which has higher valuation and earnings, MDXG or APYX?

Is MDXG or APYX more profitable?

Do insiders and institutionals have more ownership in MDXG or APYX?

Does the media refer more to MDXG or APYX?

Which has more risk and volatility, MDXG or APYX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools